PharmaEssentia
$1,165.00Change from previous close: −0.43%Absolute change: −$5.00
Valuation
Data as of October 3, 2026
Valuation multiples
- Market cap
- $481.28B
- Enterprise value
- $459.36B
- P/E (trailing 12 months)
- 63.3
- Forward P/E
- 28.2
- Price/book
- 13.1
- Price/sales
- 23.2
- EV/EBITDA
- 56.4
- EV/revenue
- 22.1
Profitability and growth
- Gross margin
- 90.9%
- Operating margin
- 46.0%
- Net margin
- 36.8%
- ROE
- 23.3%
- ROA
- 12.9%
- Revenue growth (year over year)
- 90.3%
- Earnings growth (year over year)
- 203.5%
Financial health
- Total cash
- $24.47B
- Total debt
- $1.02B
- Debt/equity
- 0.03
- Current ratio
- 5.28
- Quick ratio
- 4.76
Dividends
- Annual dividend per share
- $1.49
- Dividend yield
- 0.1%
- Payout ratio
- 4.8%
- Ex-dividend date
- July 9, 2026
Analysts and estimates
- Average price target
- $1,482.61
- Median price target
- $1,509.92
- High price target
- $2,143.00
- Low price target
- $555.00
- Analysts with a price target
- 8
- Consensus
- Buy
- Forward EPS
- $41.28
- EPS estimate, current year
- $27.46
Shares and trading
- Beta
- 0.65
- Average volume
- 3.5M
- Shares outstanding
- 413.11M
- Float
- 330.92M
- Institutional ownership
- 21.0%
- Insider ownership
- 12.4%